Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "GlaxoSmithKline"

50 News Found

SKYCovione will strengthen South Korea position in global COVID-19 vaccine industry, says GlobalData
News | July 27, 2022

SKYCovione will strengthen South Korea position in global COVID-19 vaccine industry, says GlobalData

This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines


Strides receives USFDA approval for Ibuprofen OTC oral suspension
Drug Approval | June 12, 2022

Strides receives USFDA approval for Ibuprofen OTC oral suspension

Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.


Aleor Dermaceuticals receives USFDA approval for Docosanol Cream
Drug Approval | May 04, 2022

Aleor Dermaceuticals receives USFDA approval for Docosanol Cream

Docosanol Cream, 10% (OTC) has an estimated market size of US$60 million for twelve months ending December 2021 according to IQVIA


GSK launches once daily, single inhaler-triple therapy for COPD patients
Drug Approval | April 26, 2022

GSK launches once daily, single inhaler-triple therapy for COPD patients

Trelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated with less inhaler teaching time compared to other commonly used inhalers


GSK to acquire Sierra Oncology for US $1.9bn
Biotech | April 18, 2022

GSK to acquire Sierra Oncology for US $1.9bn

Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022


LifeMine Therapeutics and GSK enter drug discovery and development alliance
Biotech | March 24, 2022

LifeMine Therapeutics and GSK enter drug discovery and development alliance

The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules


Canada approves plant-based Covid-19 vaccine
News | February 25, 2022

Canada approves plant-based Covid-19 vaccine

Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine


GSK introduces Haleon to the world
News | February 23, 2022

GSK introduces Haleon to the world

Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum


GSK pauses phase III RSV maternal vaccine candidate programme
News | February 20, 2022

GSK pauses phase III RSV maternal vaccine candidate programme

This decision does not impact the ongoing AReSVi 006 phase III trial for RSV older adults.


Medicago and GSK’s plant based Covid-19 vaccine candidate show promise in Phase 3 trials
Biotech | December 10, 2021

Medicago and GSK’s plant based Covid-19 vaccine candidate show promise in Phase 3 trials

Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants